By Turna Ray
Despite significant legal and regulatory challenges on the horizon, Myriad Genetics remained on message at an investor meeting this week, maintaining that none of these hurdles will impact the company's business going forward.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now. Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.
Japan needs to catch up on its gene-editing research efforts, the Japan News writes.
Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.
Jeff Huber, former Google X senior vice president, joins Grail as its CEO.
This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.